23/06/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
23/06/2024
Jun 23, 2024, 13:10 |
Insight
Myeloma Paper of the Day, June 23rd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: ARID1A, a member of SWI/SNF…
Jun 23, 2024, 13:08 |
Drugs
Capivasertib is now approved in EU for HR+/HER2- breast cancer
Paolo Tarantino shared a post on X: "Capivasertib is now approved in EU for the…
Jun 23, 2024, 13:01 |
Blog
Naveen Pemmaraju: Intersection of Multiple Myeloma and Myeloproliferative Neoplasms
Naveen Pemmaraju shared a post on X: "Intersection of multiple myeloma and Myeloproliferative Neoplasms! Joseph…
Jun 23, 2024, 12:49 |
Career
Carmen Uscatu: No one can accomplish anything of significance alone
Carmen Uscatu, Founder and President of Give Life, shared a post on LinkedIn: "No one…
Jun 23, 2024, 11:52 |
Insight
Ruben Mesa: So exciting to have ACS chief patient officer Arif Kamal visit us at Atrium Health
Ruben Mesa shared a post on LinkedIn: “So exciting to have American Cancer Society Chief…
Jun 23, 2024, 11:28 |
Insight
Douglas Flora: One of the best oncology educators out there
Douglas Flora shared a post by Sanjay Juneja, Editorial Board Member at AI in Precision Oncology, on…
Jun 23, 2024, 11:25 |
Insight
Carmen Monge-Montero: We finished the ‘Equity, Diversity, and Inclusion Principles in Cancer Care’ Training Event
Carmen Monge-Montero, Researcher and patient advocate at Youth Cancer Europe, recently shared a post on…
Jun 23, 2024, 11:21 |
Insight
Wafik S. El-Deiry: Historic moment in Rhode Island Healthcare
Wafik S. El-Deiry shared on LinkedIn: “Historic moment in Rhode Island Healthcare with big announcement…
Jun 23, 2024, 11:13 |
Blog
The new Impact Factor for ESMO Open has just been released
ESMO Open shared on X: "The new Impact Factor for ESMO Open has just been…
Jun 23, 2024, 11:08 |
Drugs
Vinay Prasad: We look at all Adjuvant and Neoadjuvant drugs approved by FDA in last 5 years
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
3
4
5
6
7
All:
96
Posts:
41 - 50
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube